|
1
|
Koch M, Freundl AJ, Agaimy A, Kiesewetter
F, Künzel J, Cicha I and Alexiou C: Atypical
fibroxanthoma-histological diagnosis, immunohistochemical markers
and concepts of therapy. Anticancer Res. 35:5717–5735.
2015.PubMed/NCBI
|
|
2
|
Kim YS, Lee HM, Kim JP and Lim CR: Unusual
presentation of a type 1 Monteggia equivalent lesion: Simultaneous
medial humeral condyle fracture with ipsilateral anterior
dislocation of the radial head and acute plastic bowing of the
ulna. J Pediatr Orthop B. 23:383–388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tchernev G, Tronnier M, Ananiev J, Taneva
T, Patterson JW, Gulubova M, Trafeli JP, Gegova A, Harrell M,
Guarneri C, et al: Atypical fibroxanthoma-a diagnosis of exclusion!
Wien Med Wochenschr. 163:380–386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ziemer M: Atypical fibroxanthoma. J Dtsch
Dermatol Ges. 10:537–550. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Helbig D, Ihle MA, Pütz K, Tantcheva-Poor
I, Mauch C, Büttner R and Quaas A: Oncogene and therapeutic target
analyses in atypical fibroxanthomas and pleomorphic dermal
sarcomas. Oncotarget. 7:21763–21774. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weiss A, Vanchinathan V and Kwon EJ:
Aberrant tyrosinase expression in an atypical fibroxanthoma: A case
report. J Cutan Pathol. 44:467–469. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lopez L and Velez R: Atypical
fibroxanthoma. Arch Pathol Lab Med. 140:376–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Toll A, Gimeno J, Baró T, Hernández-Munoz
MI and Pujol RM: Study of epithelial to mesenchymal transition in
atypical fibroxanthoma and undifferentiated pleomorphic sarcoma to
discern an epithelial origin. Am J Dermatopathol. 38:270–277. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mahalingam S, Shah A and Stewart A:
Atypical Fibroxanthoma: A case series and review of literature.
Auris Nasus Larynx. 42:469–471. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Feraudy S, Mar N and McCalmont TH:
Evaluation of CD10 and procollagen 1 expression in atypical
fibroxanthoma and dermatofibroma. Am J Surg Pathol. 32:1111–1122.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gleason BC, Calder KB, Cibull TL, Thomas
AB, Billings SD, Morgan MB, Hiatt KM and Smoller BR: Utility of p63
in the differential diagnosis of atypical fibroxanthoma and spindle
cell squamous cell carcinoma. J Cutan Pathol. 36:543–547. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tallon B and Beer TW: MITF positivity in
atypical fibroxanthoma. Am J Dermatopathol. 38:165–166. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Andres C, Puchta U and Flaig MJ: Detection
of Merkel cell polyomavirus DNA in atypical fibroxanthoma in
correlation to clinical features. Am J Dermatopathol. 32:799–803.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Conti BJ, Devaraneni PK, Yang Z, David LL
and Skach WR: Cotranslational stabilization of Sec62/63 within the
ER Sec61 translocon is controlled by distinct substrate-driven
translocation events. Mol Cell. 58:269–283. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meyer HA, Grau H, Kraft R, Kostka S, Prehn
S, Kalies KU and Hartmann E: Mammalian Sec61 is associated with
Sec62 and Sec63. J Biol Chem. 275:14550–14557. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lakkaraju AK, Thankappan R, Mary C,
Garrison JL, Taunton J and Strub K: Efficient secretion of small
proteins in mammalian cells relies on Sec62-dependent
posttranslational translocation. Mol Biol Cell. 23:2712–2722. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lang S, Benedix J, Fedeles SV, Schorr S,
Schirra C, Schäuble N, Jalal C, Greiner M, Hassdenetufel S, Tatzelt
J, et al: Different effects of Sec61α, Sec62 and Sec63 depletion on
transport of polypeptides into the endoplasmic reticulum of
mammalian cells. J Cell Sci. 125:1958–1969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Müller L, de Escauriaza MD, Lajoie P,
Theis M, Jung M, Müller A, Burgard C, Greiner M, Snapp EL, Dudek J
and Zimmermann R: Evolutionary gain of function for the ER membrane
protein Sec62 from yeast to humans. Mol Biol Cell. 21:691–703.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Erdmann F, Schäuble N, Lang S, Jung M,
Honigmann A, Ahmad M, Dudek J, Benedix J, Harsmann A, Kopp A, et
al: Interaction of calmodulin with Sec61α limits Ca2+ leakage from
the endoplasmic reticulum. EMBO J. 30:17–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lang S, Erdmann F, Jung M, Wagner R,
Cavalie A and Zimmermann R: Sec61 complexes form ubiquitous ER Ca2+
leak channels. Channels (Austin). 5:228–235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Linxweiler M, Schorr S, Schäuble N, Jung
M, Linxweiler J, Langer F, Schäfers HJ, Cavalié A, Zimmermann R and
Greiner M: Targeting cell migration and the endoplasmic reticulum
stress response with calmodulin antagonists: A clinically tested
small molecule phenocopy of SEC62 gene silencing in human tumor
cells. BMC Cancer. 13:5742013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schäuble N, Lang S, Jung M, Cappel S,
Schorr S, Ulucan Ö, Linxweiler J, Dudek J, Blum R, Helms V, et al:
BiP-mediated closing of the Sec61 channel limits Ca2+ leakage from
the ER. EMBO J. 31:3282–3296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bockmühl U, Schwendel A, Dietel M and
Petersen I: Distinct patterns of chromosomal alterations in high-
and low-grade head and neck squamous cell carcinomas. Cancer Res.
56:5325–5329. 1996.PubMed/NCBI
|
|
24
|
Sheu JJ, Lee CH, Ko JY, Tsao GS, Wu CC,
Fang CY, Tsai FJ, Hua CH, Chen CL and Chen JY: Chromosome
3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of
advanced nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers
Prev. 18:2709–2716. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jung V, Kindich R, Kamradt J, Jung M,
Müller M, Schulz WA, Engers R, Unteregger G, Stöckle M, Zimmermann
R and Wullich B: Genomic and expression analysis of the 3q25-q26
amplification unit reveals TLOC1/SEC62 as a probable target gene in
prostate cancer. Mol Cancer Res. 4:169–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang YC, Yeh KT, Liu TC and Chang JG:
Molecular cytogenetic characterization of esophageal cancer
detected by comparative genomic hybridization. J Clin Lab Anal.
24:167–174. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Allen DG, White DJ, Hutchins AM, Scurry
JP, Tabrizi SN, Garland SM and Armes JE: Progressive genetic
aberrations detected by comparative genomic hybridization in
squamous cell cervical cancer. Br J Cancer. 83:1659–1663. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Heselmeyer K, Macville M, Schröck E,
Blegen H, Hellström AC, Shah K, Auer G and Ried T: Advanced-stage
cervical carcinomas are defined by a recurrent pattern of
chromosomal aberrations revealing high genetic instability and a
consistent gain of chromosome arm 3q. Genes Chromosomes Cancer.
19:233–240. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haverty PM, Hon LS, Kaminker JS, Chant J
and Zhang Z: High-resolution analysis of copy number alterations
and associated expression changes in ovarian tumors. BMC Med
Genomics. 2:212009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dehan E, Ben-Dor A, Liao W, Lipson D,
Frimer H, Rienstein S, Simansky D, Krupsky M, Yaron P, Friedman E,
et al: Chromosomal aberrations and gene expression profiles in
non-small cell lung cancer. Lung Cancer. 56:175–184. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bochen F, Adisurya H, Wemmert S, Lerner C,
Greiner M, Zimmermann R, Hasenfus A, Wagner M, Smola S, Pfuhl T, et
al: Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis
and clinical outcome of head and neck squamous cell carcinomas.
Oncotarget. 8:4922–4934. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Linxweiler M, Linxweiler J, Barth M,
Benedix J, Jung V, Kim YJ, Bohle RM, Zimmermann R and Greiner M:
Sec62 bridges the gap from 3q amplification to molecular cell
biology in non-small cell lung cancer. Am J Pathol. 180:473–483.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wemmert S, Lindner Y, Linxweiler J,
Wagenpfeil S, Bohle R, Niewald M and Schick B: Initial evidence for
Sec62 as a prognostic marker in advanced head and neck squamous
cell carcinoma. Oncol Lett. 11:1661–1670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weng L, Du J, Zhou Q, Cheng B, Li J, Zhang
D and Ling C: Identification of cyclin B1 and Sec62 as biomarkers
for recurrence in patients with HBV-related hepatocellular
carcinoma after surgical resection. Mol Cancer. 11:392012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fumagalli F, Noack J, Bergmann TJ,
Cebollero E, Pisoni GB, Fasana E, Fregno I, Galli C, Loi M, Soldà
T, et al: Translocon component Sec62 acts in endoplasmic reticulum
turnover during stress recovery. Nat Cell Biol. 18:1173–1184. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Greiner M, Kreutzer B, Jung V, Grobholz R,
Hasenfus A, Stöhr RF, Tornillo L..Dudek J, Stöckle M, Unteregger G,
et al: Silencing of the SEC62 gene inhibits migratory and invasive
potential of various tumor cells. Int J Cancer. 128:2284–2295.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Greiner M, Kreutzer B, Lang S, Jung V,
Cavalié A, Unteregger G, Zimmermann R and Wullich B: Sec62 protein
level is crucial for the ER stress tolerance of prostate cancer.
Prostate. 71:1074–1083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hagerstrand D, Tong A, Schumacher SE, Ilic
N, Shen RR, Cheung HW, Vazquez F, Shresta Y, Kim SY, Giacomelli AO,
et al: Systematic interrogation of 3q26 identifies TLOC1 and SKIL
as cancer drivers. Cancer Discov. 3:1044–1057. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Linxweiler M, Bochen F, Schick B, Wemmert
S, Al Kadah B, Greiner M, Hasenfus A, Bohle RM, Juhasz-Böss I,
Solomayer EF and Takacs ZF: Identification of SEC62 as a potential
marker for 3q amplification and cellular migration in dysplastic
cervical lesions. BMC Cancer. 16:6762016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.PubMed/NCBI
|
|
41
|
Feng H, Shuda M, Chang Y and Moore PS:
Clonal integration of a polyomavirus in human Merkel cell
carcinoma. Science. 319:1096–1100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sperling T, Oldak M, Walch-Rückheim B,
Wickenhauser C, Doorbar J, Pfister H, Malejczyk M, Majewski S,
Keates AC and Smola S: Human papillomavirus type 8 interferes with
a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine
expression and Langerhans cell migration. PLoS Pathog.
8:e10028332012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mentzel T, Requena L and Brenn T: Atypical
Fibroxanthoma revisited. Surg Pathol Clin. 10:319–335. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Luo GG and Ou JH: Oncogenic viruses and
cancer. Virol Sin. 30:83–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Álvarez-Argüelles ME, Melón S, Rojo S,
Fernandez-Blázquez A, Boga JA, Palacio A, Vivanco B and de Oña M:
Detection and quantification of Merkel cell polyomavirus. Analysis
of Merkel cell carcinoma cases from 1977 to 2015. J Med Virol.
89:2224–2229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mancuso G, Antona J, Sirini C, Salvo M,
Giacometti L, Olivero C, Trisolini E, Indellicato R and Boldorini
R: Frequent detection of Merkel cell polyomavirus DNA in tissues
from 10 consecutive autopsies. J Gen Virol. 98:1372–1376. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Foulongne V, Sauvage V, Hebert C, Dereure
O, Cheval J, Gouilh MA, Pariente K, Segondy M, Burguière A,
Manuguerra JC, et al: Human skin microbiota: High diversity of DNA
viruses identified on the human skin by high throughput sequencing.
PLoS One. 7:e384992012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu W, Yang R, Payne AS, Schowalter RM,
Spurgeon ME, Lambert PF, Xu X, Buck CB and You J: Identifying the
target cells and mechanisms of merkel cell polyomavirus infection.
Cell Host Microbe. 19:775–787. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu W, MacDonald M and You J: Merkel cell
polyomavirus infection and Merkel cell carcinoma. Curr Opin Virol.
20:20–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nonaka D and Bishop PW: Sarcoma-like tumor
of head and neck skin. Am J Surg Pathol. 38:956–965. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ivan D and Prieto VG: An update on
reporting histopathologic prognostic factors in melanoma. Arch
Pathol Lab Med. 135:825–829. 2011.PubMed/NCBI
|
|
52
|
Balch CM, Gershenwald JE, Soong SJ,
Thimpson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–1206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Linxweiler M, Schick B and Zimmermann R:
Let's talk about Sec62: Sec61, Sec62 and Sec63 in signal
transduction, oncology and personalized medicine. Signal Transduct
Target Ther. 2:170022017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Helwig EB and May D: Atypical
fibroxanthoma of the skin with metastasis. Cancer. 57:368–376.
1986. View Article : Google Scholar : PubMed/NCBI
|
